# First Report of Stenotrophomonas maltophilia from Canine Dermatological Infections: Unravelling Its Antimicrobial Resistance, Biofilm Formation, and Virulence Traits

**Authors:** Ria Rajeev, Porteen Kannan, Sureshkannan Sundaram, Sandhya Bhavani Mohan, Sivachandiran Radjendirane, Chaudhary Jeetendrakumar Harnathbhai, Anbazhagan Subbaiyan, Viswanathan Naveenkumar, Nithya Quintoil Mohanadasse, Wilfred Ruban Savariraj, Charley A. Cull, Raghavendra G. Amachawadi

PMC · DOI: 10.3390/antibiotics14070639 · Antibiotics · 2025-06-23

## TL;DR

This study reports the first occurrence of S. maltophilia in dogs with skin infections, highlighting its antibiotic resistance, biofilm formation, and potential to spread to humans.

## Contribution

First documentation of S. maltophilia in canine dermatological infections with detailed analysis of its resistance and virulence traits.

## Key findings

- 15 S. maltophilia isolates showed resistance to cefpodoxime and aztreonam but susceptibility to several other antibiotics.
- High efflux activity and biofilm formation were observed in most isolates, indicating strong virulence potential.
- Resistance and virulence genes were positively correlated, suggesting co-evolution of these traits.

## Abstract

Background/Objectives: The present study was aimed at documenting S. maltophilia occurrence in dogs with skin ailments, investigating its virulence, biofilm-forming ability, antimicrobial susceptibility, and zoonotic potential to inform preventive and therapeutic strategies against multidrug resistant S. maltophilia infections. Methods: Skin swabs (n = 300) were collected from dogs with dermatological ailments. Isolation was performed using selective media and confirmed with molecular methods, validated by MALDI Biotyper. Antimicrobial susceptibility testing and efflux activity assessment were conducted. Resistance genes related to sulfonamides, quinolones, and β-lactams were screened. Virulence was assessed by biofilm formation, motility, and virulence gene profiling. Results: In total, 15 S. maltophilia (5%) isolates were identified. All 15 isolates were susceptible to trimethoprim-sulfamethoxazole, enrofloxacin, gatifloxacin, levofloxacin, minocycline, and tigecycline, but resistant to cefpodoxime and aztreonam. The following resistance genes qnr (93.3%), blaOXA-48 (46.7%), blaKPC (33.3%), blaNDM (33.3%), blaCTX-M (20%), blaSHV (20%), and blaTEM (6.7%) were detected. All 15 isolates displayed high efflux activity. Overall, 9 isolates (60%) were strong biofilm producers, and 6 (40%) were moderate. Virulence genes such as virB, motA, rmlA, and fliC were present in all 15 isolates, with others varying in frequency. All isolates exhibited swimming motility. Heat map clustering showed diverse profiles, with no identical isolate patterns. Correlation analysis indicated positive associations between several antimicrobial resistance and virulence genes. Conclusions: This study underscores the zoonotic potential of S. maltophilia from dogs, advocating for a One Health approach to mitigate infection risks and limit the spread of virulent multidrug resistant pathogens.

## Linked entities

- **Genes:** blaCTX-M (CTX-M family extended-spectrum class A beta-lactamase) [NCBI Gene 85161177], bla SHV (class A extended-spectrum beta-lactamase SHV-2) [NCBI Gene 40101717], virB (transcriptional activator VirB) [NCBI Gene 1237991], FREM1 (FRAS1 related extracellular matrix 1) [NCBI Gene 158326], rmlA (glucose-1-phosphate thymidylyltransferase) [NCBI Gene 879990], fliC (flightless C) [NCBI Gene 45294]
- **Chemicals:** trimethoprim-sulfamethoxazole (PubChem CID 358641), enrofloxacin (PubChem CID 71188), gatifloxacin (PubChem CID 5379), levofloxacin (PubChem CID 149096), minocycline (PubChem CID 54675783), tigecycline (PubChem CID 54686904), cefpodoxime (PubChem CID 6335986), aztreonam (PubChem CID 5742832)
- **Species:** Canis lupus familiaris (taxon 9615)

## Full-text entities

- **Diseases:** Dermatological Infections (MESH:D000168), S. maltophilia infections (MESH:D007239), skin ailments (MESH:D012871)
- **Chemicals:** aztreonam (MESH:D001398), tigecycline (MESH:D000078304), sulfonamides (MESH:D013449), beta-lactams (MESH:D047090), trimethoprim-sulfamethoxazole (MESH:D015662), minocycline (MESH:D008911), enrofloxacin (MESH:D000077422), quinolones (MESH:D015363), levofloxacin (MESH:D064704), gatifloxacin (MESH:D000077734), cefpodoxime (MESH:C053268)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Stenotrophomonas maltophilia (species) [taxon 40324]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12291639/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12291639/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12291639/full.md

---
Source: https://tomesphere.com/paper/PMC12291639